Received Prior First-line Chemotherapy for DLBCL or HGBL, Failed to Reach CR for Four Cycles, or Relapsed
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase II Trial of Tirelizumab Combined With R2-ICE Regimen in the Treatment of rrDLBCL/HGBL (NCT05050630) | Affiliated Hospital to Academy of Military Medical Sciences | 2021-08-01 |
Track Received Prior First-line Chemotherapy for DLBCL or HGBL, Failed to Reach CR for Four Cycles, or Relapsed automatically
Every clearance here is in the API, with alerts when new ones post.